Company page

Egetis Therapeutics Ab

Egetis Therapeutics AB is a public company listed under the ticker EGTX on the Swedish market. The company has a market capitalization of approximately 315.2 million SEK. Egetis focuses on developing innovative therapies to address unmet medical needs.

EGTX:OMXSTOUpdated August 22, 2026
Egetis Therapeutics Ab logo
Ticker
EGTX:OMXSTO
Asset type
Stock
Market cap
$332.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK